Does anyone know about or have any experience with CGTG-102?

It was recently granted orphan drug status and apparently there is a Finnish phase 1 trial.

Here's a link: http://www.healio.com/hematology-oncology/sarcoma/news/online/%7B817cf604-6cc5-4bca-b2a8-d0e4ab069707%7D/fda-ema-grant-orphan-drug-status-to-cgtg-102-for-soft-tissue-sarcoma

Here is an article about an early trial:

http://www.ncbi.nlm.nih.gov/pubmed/23493351

It sounds interesting.